ctrl K

Black Diamond Therapeutic... (BDTX)

NASDAQ: BDTX · Real-Time Price · USD

1.78

0.08 (4.71%)

At close: May 02, 2025, 3:59 PM

1.78

-0.01%

After-hours: May 02, 2025, 05:13 PM EDT

Black Diamond Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	437K	3.24M	2.22M	600K	47K	44K	24K
Gross Profit	n/a	-437K	-3.24M	-2.22M	-600K	-47K	-44K	-24K
Operating Income	-78.78M	-86.46M	-92.83M	-126.87M	-69.57M	-8.9M	-8.9M	-4.12M
Interest Income	2.18M	1.92M	2.03M	3.46M	4.04M	461K	4K	n/a
Pretax Income	-69.68M	-82.44M	-88.92M	-125.6M	-67.25M	-35.26M	-8.93M	-4.6M
Net Income	-69.68M	-82.44M	-84.52M	-123.2M	-65.48M	-41.14M	-8.93M	-4.6M
Selling & General & Admin	27.47M	27.11M	28.39M	30.04M	21.36M	7.58M	1.95M	666K
Research & Development	50.97M	58.91M	64.44M	96.83M	48.21M	21.75M	6.95M	3.45M
Other Expenses	n/a	n/a	-354K	-2.19M	-1.72M	6K	-16K	-6K
Operating Expenses	78.78M	86.46M	92.83M	126.87M	69.57M	29.33M	8.9M	4.12M
Interest Expense	n/a	n/a	n/a	n/a	1K	n/a	n/a	65K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	86.46M	92.83M	126.87M	69.57M	29.33M	8.9M	4.12M
Income Tax Expense	n/a	n/a	-4.4M	-2.39M	-1.77M	5.88M	-27K	59K
Shares Outstanding (Basic)	55.03M	43.95M	36.33M	36.19M	32.91M	35.91M	13.95M	7.2M
Shares Outstanding (Diluted)	55.03M	43.95M	36.33M	36.19M	32.91M	35.91M	13.95M	7.2M
EPS (Basic)	-1.27	-1.88	-2.33	-3.4	-1.99	-1.15	-0.64	-0.64
EPS (Diluted)	-1.27	-1.88	-2.33	-3.4	-1.99	-1.15	-0.64	-0.64
EBITDA	-69.33M	-86.02M	-92.32M	-126.67M	-66.65M	-29.29M	-8.89M	-4.09M
EBIT	n/a	-86.46M	-92.83M	-126.87M	-67.25M	-29.33M	-8.93M	-4.12M
Depreciation & Amortization	n/a	437K	3.24M	2.22M	600K	47K	44K	24K